Standard BioTools Inc (NAS:LAB)
$ 2.05 -0.06 (-2.84%) Market Cap: 758.34 Mil Enterprise Value: 387.95 Mil PE Ratio: 0 PB Ratio: 1.35 GF Score: 72/100

Standard BioTools Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript

Mar 21, 2023 / 07:00PM GMT
Release Date Price: $2.11 (+3.94%)
Paul Knight
KeyBanc Capital Markets - Analyst

This is Paul Knight at KeyBanc. I'm the life science analyst covering life science tools industry. Today, we have Standard BioTools presenting. I've gotten to know Michael Egholm and his team over the last year or more. Michael will go into his background, but a long history in the life science industry.

Also, Scott Greenstone is with us today, the Investor Relations Head. But the format is that we have Michael doing a presentation, then we'll open it up for Q&A. You can do the questions through a chat link on your screen or just e-mail me at [email protected].

So with that, Michael, I'll let you start with the overview.

Michael Egholm
Standard BioTools, Inc. - President and CEO

Thank you, Paul, and really appreciate the opportunity to present on Standard BioTools.

I will be making forward-looking statements, so I'm required to show you this slide.

And now that I've done that, the opportunity and the problem we are solving at Standard BioTools is that there are many

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot